Mara Goldstein
Stock Analyst at Mizuho
(0.5)
# 2498
Out of 5,356 analysts
92
Total ratings
29.41%
Success rate
-8.03%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KURA Kura Oncology | Maintains: Outperform | 32 30 | 6.57 | 356.62% | 3 | May 19, 2025 | |
IOVA Iovance Biotherapeut... | Maintains: Outperform | 30 10 | 1.79 | 458.66% | 5 | May 12, 2025 | |
VSTM Verastem | Maintains: Outperform | 9 8 | 6.17 | 29.66% | 7 | Apr 9, 2025 | |
RCUS Arcus Biosciences | Maintains: Buy | 51 42 | 9.65 | 335.23% | 4 | Jan 30, 2024 | |
XNCR Xencor | Maintains: Buy | 59 50 | 9.12 | 448.25% | 2 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 11.15 | 303.59% | 1 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 82 77 | 67.2 | 14.58% | 5 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 7 | 1.57 | 345.86% | 3 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 1.35 | 492.59% | 5 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 12 | 0.4 | 2900% | 5 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 6 | 0.67 | 795.52% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 | 3.92 | -10.71% | 5 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 40 30 | n/a | n/a | 3 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | 0.12 | 299900% | 2 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 20 | 2.05 | 875.61% | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 130 | 77.59 | 67.55% | 2 | Apr 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 2 | 2.41 | -17.01% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 2 | n/a | n/a | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 12 | 2.26 | 430.97% | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 9 | 0.29 | 3003.45% | 3 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 500 | n/a | n/a | 1 | Oct 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 10 | n/a | n/a | 2 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 96 | n/a | n/a | 4 | Mar 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 20 | 32.07 | -37.64% | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 34 48 | 7.41 | 547.77% | 4 | Jul 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 135 45 | 19.52 | 130.53% | 2 | Apr 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 22800 6000 | n/a | n/a | 1 | Mar 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 12 14 | 3.65 | 283.56% | 1 | Oct 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 9 | n/a | n/a | 1 | Sep 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 15 | n/a | n/a | 1 | Jul 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 16 6 | n/a | n/a | 2 | Apr 18, 2017 |